Erythropoietin in the Treatment of Cancer

Publisher： Karger

E-ISSN： 2296-5262|28|4|181-182

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.28, Iss.4, 2005-10, pp. : 181-182

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Recombinant Human Erythropoietin in the Treatment of Chronic Anemia of Cancer

By  

Acta Haematologica, Vol. 100, Iss. 2, 1998-10 ,pp. : 115-115

Karger

Access to resources Recommend Favorite

Predicting the Hematopoietic Response to Recombinant Human Erythropoietin (Epoetin Alfa) in the Treatment of the Anemia of Cancer

By  

Oncology, Vol. 56, Iss. 1, 1999-01 ,pp. : 46-53

Karger

Access to resources Recommend Favorite

Efforts to Define a Role for Recombinant Erythropoietin in Cancer Management

By  

Oncology, Vol. 71, Iss. 3-4, 2008-06 ,pp. : 149-150

Karger

Access to resources Recommend Favorite

Simultaneous use of erythropoietin and LFM‐A13 as a new therapeutic approach for colorectal cancer

By  

BRITISH JOURNAL OF PHARMACOLOGY (ELECTRONIC), Vol. 175, Iss. 5, 2018-03 ,pp. : 743-762

John Wiley & Sons Inc

Access to resources Recommend Favorite

Beta-globin mRNA increases rapidly during erythropoietin treatment

By HAGBERG A.   BARBANY G.   LANDEGREN U.   BIRGEGÅRD G.  

Scandinavian Journal of Clinical and Laboratory Investigation, Vol. 63, Iss. 3, 2003-01 ,pp. : 239-246

Informa Healthcare

Access to resources Recommend Favorite